Taking Aim at Biogen Inc. (NasdaqGS:BIIB) Shares

Biogen Inc. (NasdaqGS:BIIB) has a Value Composite score of 52. Developed by James O’Shaughnessy, the VC score uses six valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, price to sales and shareholder yield.  The VC score is displayed as a number between 1 and 100. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company. Removing the sixth ratio (shareholder yield) we can view the Value Composite 1 score which is currently sitting at 61.

Active investing may be highly stressful at times. Investors often set up trades with the best intentions, but have the tendency to let too much emotion seep into the situation. When dealing with the emotions of market stress, investors may need to figure out how to keep emotions in check in order to make the right decision. This may come easy to some but much harder for others. Because there is no one right way to trade, investors may have to experience certain scenarios for themselves. Creating a plan from the outset may help the investor when tough decisions need to be made. Keeping cool under pressure is a trait shared by many successful investors. When the investor is focused on a plan or specific trading system, this can make things a bit easier when times get tough.

Biogen Inc. (NasdaqGS:BIIB) has a current MF Rank of 1746. Developed by hedge fund manager Joel Greenblatt, the intention of the formula is to spot high quality companies that are trading at an attractive price. The formula uses ROIC and earnings yield ratios to find quality, undervalued stocks. In general, companies with the lowest combined rank may be the higher quality picks. Biogen Inc. has a current ERP5 Rank of 3234. The ERP5 Rank may assist investors with spotting companies that are undervalued. This ranking uses four ratios. These ratios are Earnings Yield, ROIC, Price to Book, and 5 year average ROIC. When looking at the ERP5 ranking, it is generally considered the lower the value, the better.

Watching some historical volatility numbers on shares of Biogen Inc. (NasdaqGS:BIIB), we can see that the 12 month volatility is presently 28.423300. The 6 month volatility is 23.897300, and the 3 month is spotted at 26.626400. Following volatility data can help measure how much the stock price has fluctuated over the specified time period. Although past volatility action may help project future stock volatility, it may also be vastly different when taking into account other factors that may be driving price action during the measured time period. 

We can now take a quick look at some historical stock price index data. Biogen Inc. (NasdaqGS:BIIB) presently has a 10 month price index of 1.07225. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 1.14221, the 24 month is 1.08136, and the 36 month is 1.08049. Narrowing in a bit closer, the 5 month price index is 1.18103, the 3 month is 1.26916, and the 1 month is currently 1.12413.

Valuation Scores

At the time of writing, Biogen Inc. (NasdaqGS:BIIB) has a Piotroski F-Score of 3. The F-Score may help discover companies with strengthening balance sheets. The score may also be used to spot the weak performers. Joseph Piotroski developed the F-Score which employs nine different variables based on the company financial statement. A single point is assigned to each test that a stock passes. Typically, a stock scoring an 8 or 9 would be seen as strong. On the other end, a stock with a score from 0-2 would be viewed as weak.

Biogen Inc. has an M-score Beneish of -999.000000. This M-score model was developed by Messod Beneish in order to detect manipulation of financial statements. The score uses a combination of eight different variables. The specifics of the variables and formula can be found in the Beneish paper “The Detection of Earnings Manipulation”.

Investors may be interested in viewing the Gross Margin score on shares of Biogen Inc. (NasdaqGS:BIIB). The name currently has a score of 12.00000. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative.

Shifting gears, we can see that Biogen Inc. (NasdaqGS:BIIB) has a Q.i. Value of 41.00000. The Q.i. Value ranks companies using four ratios. These ratios consist of EBITDA Yield, FCF Yield, Liquidity, and Earnings Yield. The purpose of the Q.i. Value is to help identify companies that are the most undervalued. Typically, the lower the value, the more undervalued the company tends to be.

Leave a Comment